Sodium Containing Patents (Class 424/615)
  • Patent number: 10379857
    Abstract: A technique for operating a processor includes allocating an entry in a prefetch filter queue (PFQ) for a cache line address (CLA) in response to the CLA missing in an instruction cache. In response to the CLA subsequently hitting in the instruction cache, an associated prefetch value for the entry in the PFQ is updated. In response to the entry being aged-out of the PFQ, an entry in a backing array for the CLA and the associated prefetch value is allocated. In response to subsequently determining that prefetching is required for the CLA, the backing array is accessed to determine the associated prefetch value for the CLA. A cache line at the CLA and a number of sequential cache lines specified by the associated prefetch value in the backing array are then prefetched into the instruction cache.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: August 13, 2019
    Assignee: International Business Machines Corporation
    Inventors: Richard J. Eickemeyer, Sheldon B. Levenstein, David S. Levitan, Mauricio J. Serrano, Brian W. Thompto
  • Patent number: 10125359
    Abstract: Provided are electrokinetically-altered fluids (gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for using same in treating inflammation or at least one symptom thereof. The electrokinetically-altered fluid compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: November 13, 2018
    Assignee: Revalesio Corporation
    Inventors: Richard L. Watson, Anthony B. Wood, Gregory J. Archambeau
  • Patent number: 10040817
    Abstract: This invention relates to methods of stimulating the activity of the human and animal enteric nervous system. The method comprises orally administering an aminoserol, such as squalamine, a naturally occurring aminosterol isolated from Squalus acanthias, or derivatives thereof, to a subject in need.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: August 7, 2018
    Assignee: ENTERIN LABORATORIES, INC.
    Inventor: Michael Zasloff
  • Patent number: 9745567
    Abstract: Provided are electrokinetically-altered fluids (gas-enriched electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for use in treating inflammatory neurodegenerative condition or disease or at least one symptom thereof. The electrokinetically-altered fluids or therapeutic compositions and methods include electrokinetically-altered ioinic aqueous fluids optionally in combination with other therapeutic agents. Particular aspects provide for regulating or modulating intracellular signal transduction associated with said inflammatory responses by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: August 29, 2017
    Assignee: REVALESIO CORPORATION
    Inventors: Richard L. Watson, Anthony B. Wood, Gregory J. Archambeau
  • Patent number: 9737644
    Abstract: The present invention relates to coatings comprising polyethylene glycol and at least one polyphenolic polymer. In particular, the polyphenolic polymer could be selected from the group consisting of tyrosine-derived polyarylates, linear polyesteramides, dihydroxybenzoate polymers, and resorcinol-derived polymers. The coating of the present invention may also include a drug, such as an antibiotic. The coatings of the present invention are suitable for use as coatings for medical devices, such as orthopedic pins or stents.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: August 22, 2017
    Assignee: TYRX, Inc.
    Inventors: Satish Pulapura, Qing Ge
  • Patent number: 9579346
    Abstract: The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.
    Type: Grant
    Filed: May 6, 2014
    Date of Patent: February 28, 2017
    Assignees: The Regents of the Univerity of California, Neuraltus Pharmaceuticals, Inc.
    Inventors: Michael S. McGrath, Arasteh Ari Azhir
  • Patent number: 9523090
    Abstract: Provided are electrokinetically-altered fluids (gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity, and therapeutic compositions and methods for using same in treating inflammation or at least one symptom thereof. The electrokinetically-altered fluid compositions and methods include electrokinetically-altered ionic aqueous fluids optionally in combination with other therapeutic agents.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: December 20, 2016
    Assignee: Revalesio Corporation
    Inventors: Richard L. Watson, Anthony B. Wood, Gregory J. Archambeau
  • Publication number: 20150104525
    Abstract: Methods of decreasing the feed conversion rate for a subject are disclosed.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 16, 2015
    Inventors: Bristol Sorensen, Lynn Bagley
  • Patent number: 9005671
    Abstract: This invention provides concentrated aqueous biocidal solutions formed from bromine chloride, sodium hydroxide, and sulfamic acid. The weight ratio of bromine chloride:sodium hydroxide:sulfamic acid used in forming the concentrated solution is such that for every 10.5 to 11.5 parts by weight of bromine chloride used, 15.3 to 17.5 parts by weight of sodium hydroxide and 11.0 to 12.5 parts by weight of sulfamic acid are used, the biocidal solution containing at least about 100,000 ppm (wt/wt) of active bromine based on the total weight of the solution.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: April 14, 2015
    Assignee: Albemarle Corporation
    Inventor: Farah D. Azarnia
  • Patent number: 8999399
    Abstract: The invention relates to a novel combined disinfection and decontamination agent comprising at least one vitamin, at least one metal ion, at least one active-surface compound, and at least one further antimicrobial active substance. The agent according to the invention surprisingly shows nearly complete nucleic acid disintegration in addition to an improved disinfectant effect. The agent can be successfully used as a combined decontamination and disinfection agent for skin, mucous membranes, hands, wounds, and/or hair, and instruments and surfaces of all kinds.
    Type: Grant
    Filed: November 14, 2009
    Date of Patent: April 7, 2015
    Assignee: Bose Chemie GmbH
    Inventors: Thomas Lisowsky, Sven Eggerstedt, Richard Bloss, Christiane Ostermeyer, Karlheinz Esser, Frank Bürger, Barbara Krug, Yvonne Feil, Kai-Martin Mueller, Delphine Haase
  • Publication number: 20150093451
    Abstract: Methods are disclosed of the increasing resting metabolic rate of a subject comprising administering a composition comprising a mixture of reduced species and reactive oxygen species, wherein the mixture of reduced species and reactive oxygen species increases the resting metabolic rate of the subject. The reactive oxygen species can comprises at least one superoxide The process of making the composition comprises the steps of purifying water to produce ultra-pure water, combining sodium chloride to the ultra-pure water to create salinated water, and electrolyzing the salinated water at a temperature of about 4.5° C. to about 5.8° C. The electrolyzing is accomplished with an anode, a cathode and a power source. The power source comprises a transformer and a rectifier and does not comprise a filter capacitor. The method can also include contacting at least one cell of the subject with the composition.
    Type: Application
    Filed: September 9, 2014
    Publication date: April 2, 2015
    Inventors: David Neiman, Andrew Swick, Mark Snyder, Bristol Sorensen
  • Publication number: 20150093425
    Abstract: Provided are antimicrobial compositions that include peracid compositions. The peracid compositions have increased shelf life and storage stability. The antimicrobial compositions can be formulated into a hard surface disinfectant composition that includes a hydrogen peroxide generator, a peracetic acid catalyst, a slow hydrolyzing acid and optionally a carboxylic acid, where the ratio between the hydrogen peroxide generator and the peracetic acid catalyst is from about 1.5:1 to about 3:1 respectively.
    Type: Application
    Filed: September 29, 2014
    Publication date: April 2, 2015
    Applicant: ChemLink Laboratories, LLC
    Inventor: Ryan Giffin MOORE
  • Patent number: 8974915
    Abstract: PU/ZnO nanocomposites are provided wherein the addition of less than 1 vol % 33 nm ZnO nanoparticles into a PU matrix effect a decrease in the Young's Modulus and storage modulus of the polymer, while simultaneously effecting an increase glass transition temperature of the polymer. Detailed experiments are described (e.g., FTIR, DMTA, FESEM and AFM) that suggest that the reaction between hydroxyl groups of the ZnO nanoparticles and isocyanate groups of the polyurethane prepolymer disrupts the self-assembly of the phase separation in PU. Phase separation is responsible for the good mechanical properties of PU. Further, detailed experiments suggest that the increase of the glass transition temperature results from the crosslinking effect of the ZnO nanoparticles.
    Type: Grant
    Filed: March 16, 2005
    Date of Patent: March 10, 2015
    Assignee: Rensselaer Polytechnic Institute
    Inventors: Junrong Zheng, Rahmi Ozisik, Richard W. Siegel
  • Publication number: 20140086968
    Abstract: The present invention provides a chemical composition comprised of hydrogen peroxide and a nanoemulsion of long-chained alcohols which in combination these constituents act synergistically boost the kill-time rate of hydrogen peroxide. The peroxide based nanoemulsion formulation for application to skin includes a cosmetically approved peroxide containing compound present in a range to give from about 0.1 to about 4 wt./wt. % released hydrogen peroxide, an organic acid present in a concentration from about 0.01 to about 5 wt./wt. % for adjusting a pH of the formulation in a range from about pH 1 to about pH 4, a long-chained (C9 to C22) aryl and/or alkl alcohol, present in a concentration from about 0.1 to about 20 wt./wt. %, and an emollient present in a concentration from about 0.1 to about 40 wt./wt. %, and an emulsifier present in a concentration from about 0.1 to about 20 wt./wt. % to render the formulation a nanoemulsion.
    Type: Application
    Filed: March 2, 2011
    Publication date: March 27, 2014
    Inventors: Pierre Grascha, Mylene Battut
  • Patent number: 8679548
    Abstract: Described are highly concentrated liquid biocidal solutions formed in water from (a) specified bromine sources (e.g., BrCl or mixtures of BrCl and Br2) and (b) alkali metal salt of sulfamic acid and/or sulfamic acid and alkali metal base, wherein the solution contains >160,000 ppm of active bromine. Solutions of this type have been found to have greater stability than a commercially-available solution made from the same components containing 148,600 ppm of active bromine. Also described are new, water-soluble, solid state biocidal products formed by removing the water from solutions made in water from (a) and (b) irrespective of the initial concentration of active bromine. Removal of water can be accomplished by flashing or distillation at reduced pressure or preferably by spray drying. Such solid state products are typically in the form of powders or small particles, but can be compacted into larger forms preferably with the aid of one or more suitable binding agents.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: March 25, 2014
    Assignee: Albemarle Corporation
    Inventors: Christopher J. Nalepa, Robert M. Moore, Jr.
  • Patent number: 8663705
    Abstract: An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: March 4, 2014
    Assignee: Reoxcyn Discoveries Group, Inc.
    Inventors: Verdis Norton, Gary L. Samuelson
  • Publication number: 20140056991
    Abstract: Methods of mobilizing fatty acids are disclosed.
    Type: Application
    Filed: September 9, 2013
    Publication date: February 27, 2014
    Inventors: David Nieman, Andrew Swick, Mark Snyder, Bristol Sorensen
  • Publication number: 20140050801
    Abstract: A gas dissolving apparatus that combines a gas at first pressure into a working fluid, the working present at a second pressure equal to or greater than the first pressure.
    Type: Application
    Filed: April 26, 2011
    Publication date: February 20, 2014
    Applicant: G TECH LICENSING, LLC
    Inventor: Caius Araujo Martins de Camargo
  • Publication number: 20140044800
    Abstract: A liquid composition with stable reactive oxygen species and other radicals is disclosed.
    Type: Application
    Filed: August 22, 2013
    Publication date: February 13, 2014
    Inventors: Daniel Robinson, James Pack
  • Publication number: 20130243883
    Abstract: Described herein are aqueous formulations with stabilized reactive and/or radical species.
    Type: Application
    Filed: April 5, 2013
    Publication date: September 19, 2013
    Applicant: Reoxcyn Discoveries Group, Inc.
    Inventors: Verdis Norton, Gary L. Samuelson
  • Patent number: 8518456
    Abstract: Disclosed are compositions related to a substantially non-cytotoxic chlorine dioxide solution. The solution may be a thickened fluid composition. Also disclosed are methods of making and using a substantially non-cytotoxic thickened fluid compositions or solutions comprising chlorine dioxide solution. An oxidizing composition of reduced irritation is also disclosed.
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: August 27, 2013
    Assignee: BASF Corporation
    Inventors: Barry Keven Speronello, Frank S. Castellana, Linda Hratko
  • Patent number: 8512762
    Abstract: What is described are sporicidal compositions, in which hydrogen peroxide and at least one radical stabilizer are homogeneously dissolved in a methacrylate monomer or a mixture of methacrylate monomers, and the quantitative ratio of radical stabilizer to hydrogen peroxide is larger than or equal to 1 to 1. The sporicidal monomer/monomer mixture is usually used for producing single component bone cement pastes; two-component bone cement pastes or monomer solutions for polymethylmethacrylate bone cements that are based on cement powder and monomer liquid.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: August 20, 2013
    Assignee: Heraeus GmbH
    Inventors: Sebastian Vogt, Hubert Büchner
  • Patent number: 8501244
    Abstract: Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: August 6, 2013
    Assignee: Neuraltus Pharmaceuticals, Inc.
    Inventors: William Boulanger, Arasteh Ari Azhir
  • Publication number: 20130171264
    Abstract: This invention relates to disinfectant compositions comprising a first active ingredient comprising a source of acetyl radicals, and a second active ingredient comprising a source of peroxygen, the composition being soluble in water to provide a solution of peracetic acid.
    Type: Application
    Filed: June 17, 2011
    Publication date: July 4, 2013
    Applicant: MTP INNOVATIONS
    Inventor: Peter Finan
  • Patent number: 8455010
    Abstract: A balanced redox-signaling compound with reactive molecules that mimic those naturally occurring inside cells that have been precisely stabilized and formulated as a supplement for oral consumption acting to enhance proper immune system function, enhance the efficiency and production of the body's native antioxidants as well as enhance the performance of intercellular communications involved in healthy tissue maintenance and athletic performance.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: June 4, 2013
    Assignee: Reoxcyn Discoveries Group, Inc
    Inventors: Verdis Norton, Gary L. Samuelson
  • Patent number: 8414932
    Abstract: Described are highly concentrated liquid biocidal solutions formed in water from (a) specified bromine sources (e.g., BrCl or mixtures of BrCl and Br2) and (b) alkali metal salt of sulfamic acid and/or sulfamic acid and alkali metal base, wherein the solution contains >160,000 ppm of active bromine. Solutions of this type have been found to have greater stability than a commercially-available solution made from the same components containing 148,600 ppm of active bromine. Also described are new, water-soluble, solid state biocidal products formed by removing the water from solutions made in water from (a) and (b) irrespective of the initial concentration of active bromine. Removal of water can be accomplished by flashing or distillation at reduced pressure or preferably by spray drying. Such solid state products are typically in the form of powders or small particles, but can be compacted into larger forms preferably with the aid of one or more suitable binding agents.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: April 9, 2013
    Assignee: Albemarie Corporation
    Inventors: Christopher J. Nalepa, Robert M. Moore, Jr.
  • Patent number: 8367120
    Abstract: An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.
    Type: Grant
    Filed: March 20, 2009
    Date of Patent: February 5, 2013
    Assignee: Reoxcyn Discoveries Group, Inc.
    Inventors: Verdis Norton, Gary L. Samuelson
  • Publication number: 20120263764
    Abstract: Provided are methods for treating inflammatory neurodegenerative diseases (e.g., multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, stroke/cerebral ischemia, head trauma, spinal cord injury, Huntington's disease, migraine, cerebral amyloid angiopathy, inflammatory neurodegenerative condition associated with AIDS, age-related cognitive decline; mild cognitive impairment and prion diseases in a mammal), or at least one symptom thereof in a subject by administering a therapeutic composition comprising at least one electrokinetically-altered fluids (e.g., electrokinetically-generated oxygen-enriched fluids) of the present invention. Particular aspects provide methods for inhibiting and/or modulating the function and/or activity of effector T-cells, and/or for cell-based tolerogenic therapy (e.g., by modulating development and/or function and/or activity of TREG cells and/or dendritic cells (DCs) and/or TH17 cells (e.g., ROR?t+ TH17 cells).
    Type: Application
    Filed: April 13, 2012
    Publication date: October 18, 2012
    Applicant: Revalesio Corporation
    Inventor: Richard L. WATSON
  • Publication number: 20120263799
    Abstract: “OXYGENATED CHLORINE FOR WATER TREATMENT AND ITS RESPECTIVE PROCESS OF OBTAINMENT AND APPLICATION”, more particularly it concerns a formulation of chemical compounds whose result is the obtainment of OXYGENATED CHLORINE; a highly effective compound capable of solving several problems of water treatment, mainly of swimming pools, in the process of disinfection, oxidation and combat to both organic and inorganic chloramines. The product considerably improves the process of water treatment because it reduces the time and quantity of chemical products used, as well potentiates the efficacy of sanitizing and oxidant properties of chlorine disinfectant “chlorine”, providing then advantages inherent to its applicability, making its characteristics innovative in the field.
    Type: Application
    Filed: May 20, 2010
    Publication date: October 18, 2012
    Applicant: MULTCLOR QUÍMICA IMP. E EXP. LTDA.
    Inventor: Fernando Jorge
  • Patent number: 8247435
    Abstract: The present disclosure provides for a scientific formulation useful in the treatment and prevention of human and animal diseases. A biologically effective amount of each of the components of the formulation is administered to patients in pill (or capsule) form via multiple different and identifiable pills. The compounds of the formulation are segregated into different pill types, and contain various amounts of the compounds Curcumin, Genistein, Squalamine, Vitamin E, N-Acetyl-Cysteine, Methylselenocysteine, Zinc Gluconate, B Complex, Lentinen, Coenzyme Q10 Acetyl-L-Carnitine, Lipoic Acid, Resveratrol, and Vitamin C. Furthermore, Arabinoxylan and/or Peperine may be added to the various pill formulations.
    Type: Grant
    Filed: February 19, 2009
    Date of Patent: August 21, 2012
    Inventor: Jerry T. Thornthwaite
  • Publication number: 20120207851
    Abstract: A composition for producing a biocide solution upon contact with water, the composition comprises at least a hydrogen peroxide donor and polyoxychlorine donor. The biocide solution forms reactive oxygen species when contacted by microorganisms, proteinaceous substances, and reducible organic based contaminants.
    Type: Application
    Filed: February 14, 2011
    Publication date: August 16, 2012
    Inventor: Roy W. Martin
  • Patent number: 8206752
    Abstract: A method for rejuvenating a reverse osmosis (RO) membrane which is subject to biofilm and other contaminants in an aqueous system through the use of a free molecular iodine solution at a pH of about 2.2 to 4.0.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: June 26, 2012
    Assignee: Biomedical Development Corporation
    Inventors: Gregg Siegel, Phyllis Siegel
  • Publication number: 20120128650
    Abstract: A medicament for the treatment or prevention of a microbial infection or an associated condition in a low oxygen environment characterised in that the medicament includes an extended acting oxygen generating system.
    Type: Application
    Filed: May 20, 2010
    Publication date: May 24, 2012
    Applicant: DEC INTERNATIONAL NZ LIMITED
    Inventors: Judith Mary Bragger, Rodney Wayne Claycomb
  • Publication number: 20120107415
    Abstract: The invention relates to a novel combined disinfection and decontamination agent comprising at least one vitamin, at least one metal ion, at least one active-surface compound, and at least one further antimicrobial active substance. The agent according to the invention surprisingly shows nearly complete nucleic acid disintegration in addition to an improved disinfectant effect. The agent can be successfully used as a combined decontamination and disinfection agent for skin, mucous membranes, hands, wounds, and/or hair, and instruments and surfaces of all kinds.
    Type: Application
    Filed: November 14, 2009
    Publication date: May 3, 2012
    Inventors: Thomas Lisowsky, Sven Eggerstedt, Richard Bloss, Christiane Ostermeyer, Karlheinz Esser, Frank Bürger, Barbara Krug, Yvonne Feil, Kai-Martin Mueller, Delphine Haase
  • Patent number: 8067035
    Abstract: Described herein are chlorite formulations having a pH between about 7 and about 8.5, wherein the chlorite formulations are substantially free of deleterious non-chlorite components. Described herein are chlorite formulations, including pharmaceutical formulations, which are formulated for systemic, parenteral, or intravenous administration. Described herein are methods of preparing and methods of using the chlorite formulations described herein.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: November 29, 2011
    Assignee: Neuraltus Pharmaceuticals, Inc.
    Inventors: William Boulanger, Arasteh Ari Azhir
  • Publication number: 20110212187
    Abstract: The invention relates to new antimicrobial compositions comprising a combination of—at least one organic and/or inorganic peroxide, —at least one silver source, and —at least one nitrogen containing compound which is a non glucogenic compatible solute, selected from taurine, choline and choline derivatives, trimethylamine-oxide (TMAO), ectoine and hydroxyectoine, the N-methylated aminoacids glycine betaine, dimethylglycine, sarcosine, carnitine, N-methyl alanine, trimethylamino-butyric acid, butyrobetaine and proline betaine, and the poly amino hydrocarbon compounds putrescine, cadaverine, spermine and spermidine.
    Type: Application
    Filed: September 1, 2009
    Publication date: September 1, 2011
    Applicant: TAMINCO
    Inventors: Jean-Michel Rabasse, Johan De Saegher, Marc Demuynck, Peter Roose
  • Patent number: 7955610
    Abstract: The present invention provides an antimicrobial composition for topical application, preferably for treating acne, and a method for using the composition. The composition comprises a photocatalyst mixture comprising a photocatalyst, such as titanium dioxide, and sodium perborate, magnesium silicate, and citric acid. The photocatalyst mixture is in an amount effective as an antimicrobial under visible light. The method comprises applying the composition to a target area of the skin and exposing the area to visible light.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: June 7, 2011
    Assignees: National Science and Technology Development Agency, Nonami Science (Thailand) Co., Ltd.
    Inventors: Wiwut Tanthapanichakoon, Uracha Rungsardthong, ML Sumarn Saraya, Wasana Thaitae
  • Publication number: 20100178357
    Abstract: The present invention relates to the use of combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and an oxidizing agent, for eradicating, eliminating or reducing aquatic organisms in ballast water or bilge water whereby 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile and the oxidizing agent are in respective proportions to provide a synergistic effect against fouling organisms. Suitable oxidizing agents are e.g.
    Type: Application
    Filed: August 6, 2007
    Publication date: July 15, 2010
    Inventor: Tony Mathilde Jozef Kempen
  • Publication number: 20100159027
    Abstract: What is described are sporicidal compositions, in which hydrogen peroxide and at least one radical stabilizer are homogeneously dissolved in a methacrylate monomer or a mixture of methacrylate monomers, and the quantitative ratio of radical stabilizer to hydrogen peroxide is larger than or equal to 1 to 1. The sporicidal monomer/monomer mixture is usually used for producing single component bone cement pastes; two-component bone cement pastes or monomer solutions for polymethylmethacrylate bone cements that are based on cement powder and monomer liquid.
    Type: Application
    Filed: December 17, 2009
    Publication date: June 24, 2010
    Applicant: HERAEUS MEDICAL GMBH
    Inventors: Sebastian VOGT, Hubert BÜCHNER
  • Publication number: 20100143493
    Abstract: An ophthalmic solution comprising a hydrogen peroxide source in an amount sufficient to result in between about 0.001% and about 0.01% by weight stabilized hydrogen peroxide in said formulation as a preservative, one or more ocularly-compatible hydrogen peroxide stabilizers, hydroxypropylmethylcellulose and sodium carboxymethylcellulose, as well as pharmaceutical compositions comprising such solutions, are provided.
    Type: Application
    Filed: February 19, 2010
    Publication date: June 10, 2010
    Inventor: FU-PAO TSAO
  • Publication number: 20100112087
    Abstract: A method of treating hypoxic tissue such as wound tissue comprises contacting a composition to the hypoxic tissue in a hypoxia-treatment effective amount, the composition comprising a biodegradable polymer and an inorganic peroxide incorporated into the polymer.
    Type: Application
    Filed: April 8, 2008
    Publication date: May 6, 2010
    Inventors: Benjamin S. Harrison, James J. Yoo, Anthony Atala
  • Publication number: 20100074967
    Abstract: The present invention is drawn to disinfectant or sterilant compositions, which are human safe, e.g., food grade or food safe. In one embodiment, an aqueous disinfectant or sterilant composition can comprise an aqueous vehicle, including water, from 0.001 wt % to 50 wt % of a peracid, and from 0.001 wt % to 25 wt % of a peroxide. Additionally, from 0.001 ppm to 50,000 ppm by weight of a transition metal based on the aqueous vehicle content can also be present. The composition can be substantially free of aldehydes. Alternatively or additionally, the transition metal can be in the form of a colloidal transition metal.
    Type: Application
    Filed: June 17, 2008
    Publication date: March 25, 2010
    Inventors: Daryl J. Tichy, Brian G. Larson
  • Publication number: 20100015245
    Abstract: The present invention relates to a method of inhibiting biofilms by combinations of antimicrobials, particularly with their synergistic activity against bioFilms. The antimicrobials include combination of copper ion and quaternary ammonium compound or combination of copper ion and peroxide. The invention also include methods for inhibiting biofilm-induced microbial corrosion or fouling.
    Type: Application
    Filed: April 23, 2009
    Publication date: January 21, 2010
    Inventors: Joe Harrison, Raymond Turner, Howard Ceri
  • Patent number: 7629004
    Abstract: This invention comprises a composition and the process of using the composition for removing and preventing mold, mildew, and fungal growth. The composition comprises at least one alkali metal perborate, at least one inhibiting compound selected from the group consisting of alkali metal silicates, triazoles and mixtures thereof in any ratio, at least one corrosion inhibitor, and effective amounts of surfactant.
    Type: Grant
    Filed: January 31, 2007
    Date of Patent: December 8, 2009
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: El Sayed S. Arafat, Craig A. Matzdorf, Stephen J. Spadafora, David L. Gauntt, Paul R. Roser, James A. Whitfield
  • Patent number: 7585460
    Abstract: The invention relates to a method for inhibiting the biological acidification of water which is in contact with materials containing sulfur in reduced form or with elemental sulfur, susceptible to oxidation on the part of Thiobacilli, comprising putting said materials in contact with soluble inorganic salts at concentrations ranging from 0.4 normal to saturation.
    Type: Grant
    Filed: April 26, 2004
    Date of Patent: September 8, 2009
    Assignees: ENI S.p.A., Enitecnologie S.p.A.
    Inventors: Francesco Crescenzi, Antonella Crisari, Cesare Achille Piatti
  • Patent number: 7524516
    Abstract: The corrosion inhibiting mildew remover kit includes a premeasured amount of sodium perborate, a premeasured amount of a liquid inhibitor and a premeasured amount of a liquid blend. The premeasured amount of sodium perborate, the premeasured amount of liquid inhibitor, the premeasured amount of liquid blend and water combine to form an aqueous solution that can be applied to a mildew infected area. The aqueous solution removes mildew from a mildew infected area and does not cause corrosion.
    Type: Grant
    Filed: January 26, 2006
    Date of Patent: April 28, 2009
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: El Sayed S. Arafat, Raymond D. Rose, Paul R. Roser
  • Patent number: 7494670
    Abstract: This invention comprises a composition and the process of using the composition for removing and preventing mold, mildew, and fungal growth. The composition comprises at least one alkali metal perborate, at least one inhibiting compound selected from the group consisting of alkali metal silicates, triazoles and mixtures thereof in any ratio, at least one corrosion inhibitor, and effective amounts of surfactant.
    Type: Grant
    Filed: June 10, 2005
    Date of Patent: February 24, 2009
    Assignee: United States of America as represented by the Secretary of the Navy
    Inventors: El Sayed S. Arafat, Craig A. Matzdorf, Stephen J. Spadafora, David L. Gauntt, Paul R. Roser, James A. Whitfield
  • Publication number: 20090004167
    Abstract: A method for controlling diseases caused by anaerobic agents in plants by at least partially preventing, stopping or reversing the damage caused by the anaerobic agents, comprising treating the plant or the soil in which the plant is growing or will grow with at least one inorganic peroxide. A formulation for the control of such diseases in plants, comprising at least one inorganic peroxide and at least one additive chosen from biological agents, nutrients and their mixtures.
    Type: Application
    Filed: July 13, 2005
    Publication date: January 1, 2009
    Applicant: Solvay (Societe Annonyme)
    Inventors: Noel Boulos, Marv Crumb
  • Patent number: 7175858
    Abstract: Methods and compositions for producing flowable compositions, e.g. pastes, that set into calcium phosphate products are provided. In the subject methods, dry reactants that include a calcium source and a phosphate source are combined with setting fluid to produce the flowable composition. A feature of the subject methods is that the dry reactants include a particulate calcium and/or phosphate reactant having a mean particle size of less than about 8 ?m and narrow size distribution. Also provided are the compositions themselves as well as kits for use in practicing the subject methods. The subject methods and compositions produced thereby find use in a variety of applications, including the repair of hard tissue defects, e.g., bone defects.
    Type: Grant
    Filed: July 26, 2004
    Date of Patent: February 13, 2007
    Assignee: Skeletal Kinetics LLC
    Inventors: Brent R. Constantz, David Delaney, Duran Yetkinler
  • Patent number: 7105183
    Abstract: The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.
    Type: Grant
    Filed: January 24, 2005
    Date of Patent: September 12, 2006
    Assignee: The Regents of the University of California
    Inventor: Michael S. McGrath